The effect of vitamin D supplementation on the risk of breast cancer: a trial sequential meta-analysis Liguang ZhouBo ChenAndrew Turner Review 13 May 2020 Pages: 1 - 8
Lipid biosignature of breast cancer tissues by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry Catarina L. SilvaRosa PerestreloMarijana Petković Preclinical study 15 May 2020 Pages: 9 - 19
TRPC1 inhibits the proliferation and migration of estrogen receptor-positive Breast cancer and gives a better prognosis by inhibiting the PI3K/AKT pathway Li-Ying ZhangYong-Qu ZhangLi-Juan Liu Preclinical study 15 May 2020 Pages: 21 - 33
High expression of OSR1 as a predictive biomarker for poor prognosis and lymph node metastasis in breast cancer Yang LiJun QinJunming Xu Preclinical study 18 May 2020 Pages: 35 - 46
Does sentinel lymph node biopsy for screening high-grade ductal carcinoma in situ of the breast cause more harm than good? Saed RamziErum NajeebStephanie Jenkins Preclinical study 19 May 2020 Pages: 47 - 54
Androgen receptor expression inversely correlates with histological grade and N stage in ER+/PgRlow male breast cancer Cristian ScatenaRosa ScarpittaAntonio Giuseppe Naccarato Preclinical study 21 May 2020 Pages: 55 - 65
Carboplatin plus taxanes are non-inferior to epirubicin plus cyclophosphamide followed by taxanes as adjuvant chemotherapy for early triple-negative breast cancer Feng DuWenmiao WangBinghe Xu Clinical trial 11 May 2020 Pages: 67 - 77
The natural history of untreated estrogen receptor-positive, Her2-negative invasive breast cancer Kristin E. RojasDonna-Marie ManassehPatrick I. Borgen Clinical trial 12 May 2020 Pages: 79 - 83
ABREAST: a prospective, real-world study on the effect of nab-paclitaxel treatment on clinical outcomes and quality of life of patients with metastatic breast cancer A. KoumarianouP. MakrantonakisA. Ardavanis Clinical trial 16 May 2020 Pages: 85 - 96
Prediction of pathologic complete response using image-guided biopsy after neoadjuvant chemotherapy in breast cancer patients selected based on MRI findings: a prospective feasibility trial Han-Byoel LeeWonshik HanDong-Young Noh Clinical trial 16 May 2020 Pages: 97 - 105
Patients’ perceptions of 70-gene signature testing: commonly changing the initial inclination to undergo or forego chemotherapy and reducing decisional conflict Julia E. C. van SteenhovenBianca M. den DekkerThijs van Dalen Clinical trial Open access 19 May 2020 Pages: 107 - 115
Breast-conserving surgery without axillary lymph node surgery or radiotherapy is safe for HER2-positive and triple negative breast cancer patients over 70 years of age Ying ZhongYali XuQiang Sun Clinical Trial 19 May 2020 Pages: 117 - 126
HER2-targeted therapy influences CTC status in metastatic breast cancer Thomas M. DeutschSabine RiethdorfMarkus Wallwiener Clinical trial Open access 20 May 2020 Pages: 127 - 136
EndoPredict® in early hormone receptor-positive, HER2-negative breast cancer K. AlmstedtS. MendozaM. Schmidt Clinical trial Open access 20 May 2020 Pages: 137 - 146
Association of CYP19A1 gene variations with adjuvant letrozole-induced adverse events in South Indian postmenopausal breast cancer cohort expressing hormone-receptor positivity Gurusamy UmamaheswaranDharanipragada KadambariChandrasekaran Adithan Epidemiology 08 May 2020 Pages: 147 - 158
The impact of ductal carcinoma in situ on health services utilization Lawrence PaszatRinku SutradharEileen Rakovitch Epidemiology 08 May 2020 Pages: 159 - 168
Association between the polymorphisms in MMP-2 and MMP-9 with adiposity and mammographic features Suélène Georgina DofaraSue-Ling ChangCaroline Diorio Epidemiology 11 May 2020 Pages: 169 - 179
Racial/ethnic differences in supplemental imaging for breast cancer screening in women with dense breasts Charlotte EzrattySuzanne VangJenny J. Lin Epidemiology 11 May 2020 Pages: 181 - 185
Physical activity among patients with breast cancer receiving aromatase inhibitors is associated with bone health: a cross-sectional observational study Takashi SaitoRei OnoYoshitada Sakai Epidemiology 12 May 2020 Pages: 187 - 193
Long-term excess body fat in adulthood and the risk of pre- and postmenopausal breast cancer in Chinese women Yu HaoBin XuJiayuan Li Epidemiology 15 May 2020 Pages: 195 - 206
Association between thyroid gland diseases and breast cancer: a case–control study Laura BachKarel KostevMatthias Kalder Epidemiology 18 May 2020 Pages: 207 - 213
Exploring the effects of lifestyle on breast cancer risk, age at diagnosis, and survival: the EBBA-Life study Trygve LofterødHanne FrydenbergInger Thune Epidemiology Open access 20 May 2020 Pages: 215 - 227
Synchronous bilateral breast cancer: a nationwide study on histopathology and etiology Mathias Kvist MejdahlJan WohlfahrtEva Balslev Epidemiology 21 May 2020 Pages: 229 - 238
Characteristics and outcomes of patients with breast cancer diagnosed with SARS-Cov-2 infection at an academic center in New York City Kevin KalinskyMelissa K. AccordinoDawn L. Hershman Letter to the Editor 14 May 2020 Pages: 239 - 242
Treatment options for patients with HR+/HER2− advanced breast cancer during the COVID-19 pandemic: dose reduction of ribociclib does not diminish efficacy Joyce O’Shaughnessy Letter to the Editor Open access 20 May 2020 Pages: 243 - 244
Fertility and reproduction in breast cancer patients Federica TomaoMonica VerricoSilverio Tomao Letter to the Editor 20 May 2020 Pages: 245 - 246
